American society of clinical oncology/american society of hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. J Oncol Pract 2010 Nov;6(6):317-20
Date
03/02/2011Pubmed ID
21358963Pubmed Central ID
PMC2988667DOI
10.1200/JOP.2010.000132Scopus ID
2-s2.0-79952380217 (requires institutional sign-in at Scopus site) 38 CitationsAbstract
This guideline update addresses two clinical questions: (1) What are the defining features of patients with a malignancy who are appropriate candidates for ESA treatment? (2) For patients who are appropriate candidates for treatment with ESAs, what are the optimal approaches to ESA therapy?